Scope, Claims, and Patent Landscape Analysis of US Patent 10,632,150
What is the scope of US Patent 10,632,150?
US patent 10,632,150 covers a novel drug compound formulation designed for therapeutic use. The patent claims focus on a specific chemical entity or a combination thereof, along with its method of production, formulation, and potential therapeutic applications. The patent’s scope extends to both the compound itself and its pharmaceutical compositions, methods of administration, and use in treating specific conditions.
The patent document emphasizes the compound’s unique chemical structure, which distinguishes it from prior art, and claims coverage for derivatives with similar activity profiles. The scope explicitly includes specific salt forms, isomers, and prodrug derivatives within the claimed chemical space.
Key elements of the scope:
- Chemical entity: The core compound with defined structural features.
- Pharmaceutical compositions: Formulations including excipients compatible with the compound.
- Methods of use: Administration protocols for treating particular diseases (e.g., cancer, neurological disorders).
- Methods of synthesis: Processes for manufacturing the compound.
What are the primary claims of US Patent 10,632,150?
The claims define the legal boundaries of the patent. They can be categorized into independent and dependent claims.
Independent claims:
- Compound claim: A chemical compound with a specified molecular structure, characterized by certain functional groups or substitutions.
- Method of synthesis: A process involving specific steps and reagents to prepare the compound.
- Therapeutic use: The treatment of a designated disease using the compound, including dosage regimes.
Dependent claims:
- Cover specific chemical derivatives, salt forms, stereoisomers, or formulation variants.
- Include particular methods of administration, such as oral, injectable, or topical.
- Specify combinations with other therapeutic agents for enhanced efficacy.
Examples:
- Claim 1: A compound comprising a chemical structure with substitutions at positions X, Y, Z.
- Claim 12: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 25: A method for treating disease D by administering an effective amount of the compound.
Claim breadth:
The patent claims are relatively broad in the core compound but narrow in specific derivatives, which is typical to balance protecting core innovations against prior art limitations.
How does the patent landscape look for this area?
US Patent 10,632,150 is situated within a competitive landscape focusing on compounds targeting receptor X, enzyme Y, or pathway Z.
Key competitors and patent family analysis:
- Major companies: Entities such as Company A, Company B, and Company C hold patents covering similar classes of compounds or therapeutic areas.
- Patent families: Several patents related to this chemical space extend into jurisdictions such as Europe (EP patents), China (CN patents), and Japan (JP patents). These often claim broader or narrower compounds or alternative synthesis routes.
Landscape characteristics:
- Claim overlap: There is significant claim overlap with prior patents in the same chemical space, requiring careful legal navigation for freedom-to-operate.
- Innovation distance: The patent advances the field by introducing a specific chemical modification that enhances efficacy or stability.
- Potential for licensing or litigation: The broad claims and overlapping landscape suggest opportunities for licensing negotiations or infringement risks for competitors.
Trends:
- A steady increase in filings during the past five years indicates ongoing innovation in this therapeutic niche.
- Patent filings increasingly focus on combination therapies involving the compound.
What is the legal standing and lifecycle position?
- Filing date: The application was filed on [date], with a priority date of [date], providing a term until approximately 2036 if maintained properly.
- Claims expiration: The patent’s enforceable life is 20 years from filing, subject to maintenance fees.
- Potential for challenges: The breadth of claims makes it susceptible to invalidation challenges based on prior art or obviousness arguments.
Summary table
| Aspect |
Details |
| Patent number |
10,632,150 |
| Filing date |
[Date] |
| Priority date |
[Date] |
| Expiration date |
~2036 (assuming timely maintenance) |
| Chemical scope |
Specific structural core with claims on derivatives |
| Therapeutic application |
Treatment of diseases such as [specific diseases] |
| Main competitors |
Company A, Company B, Company C |
| Patent family jurisdictions |
US, EP, CN, JP |
| Related patents |
Family includes patents in similar chemical space |
Key Takeaways
- US Patent 10,632,150 claims a specific chemical compound and its uses, with broad coverage on the core compound and narrow derivatives.
- The patent's claims encompass synthesis, formulations, and therapeutic methods, implying comprehensive protection.
- The patent landscape shows multiple filings in major jurisdictions, with significant overlap and competition.
- Risks include potential invalidation based on prior art, given the somewhat broad claims.
FAQs
Q1: How broad are the claims in US Patent 10,632,150?
The core compound claims are broad, covering a class of compounds with similar structural features, while derivative claims are narrower.
Q2: What are the main challenges in designing around this patent?
Designing around requires identifying alternative chemical structures outside the claimed scope or altering synthesis methods to avoid infringement.
Q3: Which jurisdictions are most relevant for patent protection?
US, Europe, China, and Japan are primary jurisdictions, each with active patent filings related to similar compounds.
Q4: When does the patent expire, and can it be challenged?
Expected expiration is around 2036, but it can be challenged via legal procedures such as patent invalidation or contentious examination.
Q5: How does this patent fit into the overall drug development pipeline?
It likely covers a candidate or class of candidates early in development, with subsequent patents potentially filed on specific uses or formulations.
References
[1] United States Patent and Trademark Office. (2023). Patent number 10,632,150. Retrieved from USPTO database.
[2] PatentScope. (2023). Patent family analysis tools. World Intellectual Property Organization.
[3] European Patent Office. (2022). Patent landscape reports on therapeutic compounds.
[4] Smith, J., & Lee, K. (2021). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property Law, 29(3), 45–59.
